| Literature DB >> 30174242 |
Niraj Shenoy1, Edward Creagan2, Thomas Witzig2, Mark Levine3.
Abstract
Vitamin C (ascorbic acid, ascorbate), despite controversy, has re-emerged as a promising anti-cancer agent. Recent knowledge of intravenous ascorbate pharmacokinetics and discovery of unexpected mechanisms of ascorbate action have spawned many investigations. Two mechanisms of anti-cancer activity with ascorbate have gained prominence: hydrogen peroxide-induced oxidative stress and DNA demethylation mediated by ten-eleven translocation enzyme activation. Here, we highlight salient aspects of the evolution of ascorbate in cancer treatment, provide insights into the pharmacokinetics of ascorbate, describe mechanisms of its anti-cancer activity in relation to the pharmacokinetics, outline promising preclinical and clinical evidence, and recommend future directions. Published by Elsevier Inc.Entities:
Keywords: ascorbic acid; cancer
Mesh:
Substances:
Year: 2018 PMID: 30174242 PMCID: PMC6234047 DOI: 10.1016/j.ccell.2018.07.014
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743